Republican U.S. Rep. Christopher Collins of New York has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades.
The charges were announced and the indictment unsealed in New York City on Wednesday.
The indictment charges Collins and two others, including the congressman’s son, with conspiracy, wire fraud and other counts.
Prosecutors say the charges relate to a scheme to gain insider information about a biotechnology company headquartered in Sydney, Australia, with offices in Auckland, New Zealand.
- Canada’s booze bans led to 63 per cent fall in exports: U.S. industry body
- Saskatchewan NDP legislature member to sit as Independent, says can’t support leader
- Global energy crisis will be ‘daily issue’ in Canada soon, IEA chief warns
- Ontario refuses to say if it has hired any enforcement staff for new ticket price cap
Get daily National news
According to the indictment, the defendants tried to get early word on the results of tests by Innate Immunotherapeutics Limited.
The company developed a drug intended to treat Secondary Progressive Multiple Sclerosis.
Collins has denied any wrongdoing.
Comments
Want to discuss? Please read our Commenting Policy first.